Eculizumab cas 219685-50-4
| Product name:Eculizumab Alexion | Purity:99% min |
| CAS NO:219685-50-4 | Solubility: |
| Molecular Formula: | Package:Package according to customer requirements |
| Molecular Weight:148 kg/mol | Storage:Store at -20℃ |
Eculizumab is a medication used to treat paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor.In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death.Eculizumab was the first drug approved for each of its uses, and its approval was granted on the basis of small clinical trials.
Related Products:
Alirocumab; Denosumab; Evolocumab; Omalizumab; Ustekinumab; Vedolizumab; Trastuzumab; Omalizumab; Nivolumab; Denosumab; Cetuximab; Bevacizumab; Aflibercept
Get in Touch
Have questions about our products or want to discuss a custom order? Our team is ready to help you.